This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Great Medical Stocks to Buy Ahead of Q4 Earnings
by Swarup Gupta
A Reuters review of Wall Street Research firms reveals that health care is the most favored of the S&P 500's 11 major sectors.
What's in the Cards for UnitedHealth (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 performance should benefit from robust segmental revenues along with membership growth.
Why Does the Stock of Cigna (CI) Look Attractive Now?
by Zacks Equity Research
The acquisition of Express Scripts by Cigna (CI) presents another major growth point for the company.
Are Investors Undervaluing Humana (HUM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare (MOH) in Focus: Stock Moves 7.4% Higher
by Zacks Equity Research
Molina Healthcare (MOH) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Can Humana (HUM) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Molina Renews Pact With CVS to Boost PBM Service Platform
by Zacks Equity Research
Molina (MOH) expands deal with CVS Caremark for Pharmacy Benefit Management services.
Ensign Group's (ENSG) Buyout to Expand Business in Utah
by Zacks Equity Research
Ensign Group (ENSG) acquires the real estate and operations of Bella Terra Cedar City to bolster its growth profile.
Anthem or Humana: Which HMO Stock is a Better Buy for 2019?
by Zacks Equity Research
The health insurance industry is poised for growth despite some policy disturbances; here we analyze which stock Anthem or Humana would provide greater returns in 2019.
Zacks.com featured highlights include: Darden, Esterline, Humana, IBERIABANK and United Continental
by Zacks Equity Research
Zacks.com featured highlights include: Darden, Esterline, Humana, IBERIABANK and United Continental
Is Humana (HUM) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HUM) Outperforming Other Medical Stocks This Year?
Invest in These 5 Stocks With Upgraded Broker Ratings Now
by Zacks Equity Research
It is always recommended to follow expert advise while investing in stocks. So, when a broker upgrades a stock, one can easily rely on it.
Top Ranked Growth Stocks to Buy for December 31st
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 31st
Centene Unit Collaborates With RxAdvance for New PBM Platform
by Zacks Equity Research
Centene's (CNC) Mississippi unit partners RxAdvance for establishing a transformative pharmacy benefit management model.
Are Investors Undervaluing Humana (HUM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 HMOs Likely to Cruise Ahead of Industry in 2019
by Sapna Bagaria
Players in the HMO industry should gain from aging population, expanding government business, technological investment and industry consolidation
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
Magellan Health (MGLN) Surges: Stock Moves 6.7% Higher
by Zacks Equity Research
Magellan Health (MGLN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Top Research Reports for Intuitive Surgical, HCA Healthcare & Exelon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Exelon (EXC).
Is Humana (HUM) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HUM) Outperforming Other Medical Stocks This Year?
Can a Divided Congress Boost Healthcare Stocks? 4 Picks
by Zacks Equity Research
A divided Congress ensures Obamacare stays in place.
Top Ranked Growth Stocks to Buy for December 12th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 12th:
Moody's Downgrades Acadia's (ACHC) Outlook, Affirms Ratings
by Zacks Equity Research
Acadia Healthcare (ACHC) receives rating actions from Moody's. Outlook down to negative from stable.
Top Ranked Growth Stocks to Buy for December 10th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 10th: